'Thoughtless Interference': HCG CMD On Cancer Drug Price Curbs
Indian markets moved lower in a quarterly results development.
· NDTV Profit
HCG's Ajai Kumar says the MRP can be cut, but the 30% trade margin cap on non-scheduled cancer drugs could keep new treatments from Indian patients.
The analysis
Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
Related coverage
TCS onboards 10,000 freshers in Q2 FY27; plans to hire on demand
Up 15,400% in 5 years, multibagger stock Cupid hits record high - What's fuelling the rally? Check outlook, stop loss
15,410% rally in 5 years! Multibagger Cupid shares jump 3% to hit fresh 52-week high
ICICI Prudential Life Insurance to focus on growing absolute VNB amid slump in FY24
Tata Elxsi Q4 net profit, revenue decline QoQ; firm declares dividend of Rs 70 per share